MedPath

Multi-mOnth Refill of Anti-TB Drugs (MORAD) study in rural eastern Uganda

Phase 3
Not yet recruiting
Conditions
Tuberculosis
Registration Number
PACTR202403586718783
Lead Sponsor
niversity of California Berkeley
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
260
Inclusion Criteria

Aim 1:
1) TB focal persons with =1 year of work experience;
2) Other stakeholders with =3 years of work experience in TB;
3) People with TB on treatment for =4 months including the respective treatment supporters.

Aim 2
People with drug-susceptible PTB =15 years.

Exclusion Criteria

Aim 1
1) Unreachable participants

Aim 2:
1) People with TB who are very ill and require close clinical and laboratory monitoring or hospitalization;
2) People with PTB likely to migrate to another district/ or place during the study period;
3) Treated with anti-TB drugs for =2 months;
4) People with drug-resistant TB;
5) People with extrapulmonary TB since treatment duration exceeds 6 months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.